IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-3-031-30254-1_3.html
   My bibliography  Save this book chapter

Everything Is Economics

In: Vulnerability and the Corporate Immune System

Author

Listed:
  • Alessandro Capocchi

    (University of Milano-Bicocca)

Abstract

Everything is economics, and everything is measurable. Any behavior, decision, non-behavior, or non-decision has an economic value and is quantitatively measurable. Economic value is not unique, nor is it objective. It depends on the methodology used and the temporal depth to which it is analyzed. Therefore, the principal analysis methodologies are vital for supporting management in decision-making and strategic processes. This chapter describes the principal analysis and measurement techniques to support decision-making: opportunity cost, economic marginalism, differential analysis, and break-even analysis. Over the years, the economic value of every behavior, decision, non-behavior, and non-decision has changed the composition of organizational systems in the relationship between subjective management (i.e., human capital) and objective management (i.e., managerial tools). Managerial tools are becoming increasingly important in decision-making processes, representing a real threat to subjective management (i.e., management that takes no responsibility and tends to delegate the decision to objective evidence produced by its various analysis techniques). Technology, big data, algorithms, and artificial intelligence are essential in this context. Companies’ almost obsessive pursuit of numbers is the basis of surveillance capitalism. This tug-of-war between subjective and objective management in the digital age must make us reflect on two essential issues in companies' decision-making and management processes: the relationship between humans and technology and the relationship between rationality and irrationality.

Suggested Citation

  • Alessandro Capocchi, 2023. "Everything Is Economics," Springer Books, in: Vulnerability and the Corporate Immune System, chapter 0, pages 33-54, Springer.
  • Handle: RePEc:spr:sprchp:978-3-031-30254-1_3
    DOI: 10.1007/978-3-031-30254-1_3
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-3-031-30254-1_3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.